KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Prepaid Assets (2016 - 2025)

Boston Scientific's Prepaid Assets history spans 17 years, with the latest figure at $299.0 million for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 2.61% year-over-year to $299.0 million; the TTM value through Dec 2025 reached $299.0 million, down 2.61%, while the annual FY2025 figure was $299.0 million, 2.61% down from the prior year.
  • Prepaid Assets for Q4 2025 was $299.0 million at Boston Scientific, down from $307.0 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $874.0 million in Q2 2022 and bottomed at $202.0 million in Q2 2021.
  • The 5-year median for Prepaid Assets is $721.0 million (2022), against an average of $571.6 million.
  • The largest annual shift saw Prepaid Assets crashed 78.16% in 2021 before it surged 332.67% in 2022.
  • A 5-year view of Prepaid Assets shows it stood at $799.0 million in 2021, then decreased by 8.51% to $731.0 million in 2022, then plummeted by 56.91% to $315.0 million in 2023, then dropped by 2.54% to $307.0 million in 2024, then fell by 2.61% to $299.0 million in 2025.
  • Per Business Quant, the three most recent readings for BSX's Prepaid Assets are $299.0 million (Q4 2025), $307.0 million (Q4 2024), and $315.0 million (Q2 2024).